Literature DB >> 25646473

Overlapping hotspots in CDRs are critical sites for V region diversification.

Lirong Wei1, Richard Chahwan2, Shanzhi Wang1, Xiaohua Wang1, Phuong T Pham3, Myron F Goodman3, Aviv Bergman4, Matthew D Scharff5, Thomas MacCarthy6.   

Abstract

Activation-induced deaminase (AID) mediates the somatic hypermutation (SHM) of Ig variable (V) regions that is required for the affinity maturation of the antibody response. An intensive analysis of a published database of somatic hypermutations that arose in the IGHV3-23*01 human V region expressed in vivo by human memory B cells revealed that the focus of mutations in complementary determining region (CDR)1 and CDR2 coincided with a combination of overlapping AGCT hotspots, the absence of AID cold spots, and an abundance of polymerase eta hotspots. If the overlapping hotspots in the CDR1 or CDR2 did not undergo mutation, the frequency of mutations throughout the V region was reduced. To model this result, we examined the mutation of the human IGHV3-23*01 biochemically and in the endogenous heavy chain locus of Ramos B cells. Deep sequencing revealed that IGHV3-23*01 in Ramos cells accumulates AID-induced mutations primarily in the AGCT in CDR2, which was also the most frequent site of mutation in vivo. Replacing the overlapping hotspots in CDR1 and CDR2 with neutral or cold motifs resulted in a reduction in mutations within the modified motifs and, to some degree, throughout the V region. In addition, some of the overlapping hotspots in the CDRs were at sites in which replacement mutations could change the structure of the CDR loops. Our analysis suggests that the local sequence environment of the V region, and especially of the CDR1 and CDR2, is highly evolved to recruit mutations to key residues in the CDRs of the IgV region.

Entities:  

Keywords:  AID; IGHV3-23; complementarity-determining regions; cytosine deamination; somatic hypermutation

Mesh:

Substances:

Year:  2015        PMID: 25646473      PMCID: PMC4343087          DOI: 10.1073/pnas.1500788112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  76 in total

Review 1.  Regulation of AID, the B-cell genome mutator.

Authors:  Celia Keim; David Kazadi; Gerson Rothschild; Uttiya Basu
Journal:  Genes Dev       Date:  2013-01-01       Impact factor: 11.361

2.  Somatic hypermutation maintains antibody thermodynamic stability during affinity maturation.

Authors:  Feng Wang; Shiladitya Sen; Yong Zhang; Insha Ahmad; Xueyong Zhu; Ian A Wilson; Vaughn V Smider; Thomas J Magliery; Peter G Schultz
Journal:  Proc Natl Acad Sci U S A       Date:  2013-02-25       Impact factor: 11.205

Review 3.  AIDing antibody diversity by error-prone mismatch repair.

Authors:  Richard Chahwan; Winfried Edelmann; Matthew D Scharff; Sergio Roa
Journal:  Semin Immunol       Date:  2012-06-14       Impact factor: 11.130

Review 4.  Activation induced deaminase: how much and where?

Authors:  Alexandre Orthwein; Javier M Di Noia
Journal:  Semin Immunol       Date:  2012-06-09       Impact factor: 11.130

5.  A structural basis for the biochemical behavior of activation-induced deoxycytidine deaminase class-switch recombination-defective hyper-IgM-2 mutants.

Authors:  Yunxiang Mu; Courtney Prochnow; Phuong Pham; Xiaojiang S Chen; Myron F Goodman
Journal:  J Biol Chem       Date:  2012-06-19       Impact factor: 5.157

6.  Preconfiguration of the antigen-binding site during affinity maturation of a broadly neutralizing influenza virus antibody.

Authors:  Aaron G Schmidt; Huafeng Xu; Amir R Khan; Timothy O'Donnell; Surender Khurana; Lisa R King; Jody Manischewitz; Hana Golding; Pirada Suphaphiphat; Andrea Carfi; Ethan C Settembre; Philip R Dormitzer; Thomas B Kepler; Ruijun Zhang; M Anthony Moody; Barton F Haynes; Hua-Xin Liao; David E Shaw; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-21       Impact factor: 11.205

7.  B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study.

Authors:  Barton F Haynes; Garnett Kelsoe; Stephen C Harrison; Thomas B Kepler
Journal:  Nat Biotechnol       Date:  2012-05-07       Impact factor: 54.908

8.  Structural and genetic basis for development of broadly neutralizing influenza antibodies.

Authors:  Daniel Lingwood; Patrick M McTamney; Hadi M Yassine; James R R Whittle; Xiaoti Guo; Jeffrey C Boyington; Chih-Jen Wei; Gary J Nabel
Journal:  Nature       Date:  2012-08-29       Impact factor: 49.962

9.  Lineage structure of the human antibody repertoire in response to influenza vaccination.

Authors:  Ning Jiang; Jiankui He; Joshua A Weinstein; Lolita Penland; Sanae Sasaki; Xiao-Song He; Cornelia L Dekker; Nai-Ying Zheng; Min Huang; Meghan Sullivan; Patrick C Wilson; Harry B Greenberg; Mark M Davis; Daniel S Fisher; Stephen R Quake
Journal:  Sci Transl Med       Date:  2013-02-06       Impact factor: 17.956

10.  A role for the RNA pol II-associated PAF complex in AID-induced immune diversification.

Authors:  Katharina L Willmann; Sara Milosevic; Siim Pauklin; Kerstin-Maike Schmitz; Gopinath Rangam; Maria T Simon; Sarah Maslen; Mark Skehel; Isabelle Robert; Vincent Heyer; Ebe Schiavo; Bernardo Reina-San-Martin; Svend K Petersen-Mahrt
Journal:  J Exp Med       Date:  2012-09-24       Impact factor: 14.307

View more
  30 in total

1.  JH6 downstream intronic sequence is dispensable for RNA polymerase II accumulation and somatic hypermutation of the variable gene in Ramos cells.

Authors:  Diana P Castiblanco; Darrell D Norton; Robert W Maul; Patricia J Gearhart
Journal:  Mol Immunol       Date:  2018-04-04       Impact factor: 4.407

Review 2.  The evolution within us.

Authors:  Sarah Cobey; Patrick Wilson; Frederick A Matsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

3.  AID-RNA polymerase II transcription-dependent deamination of IgV DNA.

Authors:  Phuong Pham; Sohail Malik; Chiho Mak; Peter C Calabrese; Robert G Roeder; Myron F Goodman
Journal:  Nucleic Acids Res       Date:  2019-11-18       Impact factor: 16.971

4.  Sequence intrinsic somatic mutation mechanisms contribute to affinity maturation of VRC01-class HIV-1 broadly neutralizing antibodies.

Authors:  Joyce K Hwang; Chong Wang; Zhou Du; Robin M Meyers; Thomas B Kepler; Donna Neuberg; Peter D Kwong; John R Mascola; M Gordon Joyce; Mattia Bonsignori; Barton F Haynes; Leng-Siew Yeap; Frederick W Alt
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-26       Impact factor: 11.205

5.  Interplay between Target Sequences and Repair Pathways Determines Distinct Outcomes of AID-Initiated Lesions.

Authors:  Zhangguo Chen; Maxwell D Eder; Mihret T Elos; Sawanee S Viboolsittiseri; Xiaomi Chen; Jing H Wang
Journal:  J Immunol       Date:  2016-01-25       Impact factor: 5.422

6.  Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes.

Authors:  Leng-Siew Yeap; Joyce K Hwang; Zhou Du; Robin M Meyers; Fei-Long Meng; Agnė Jakubauskaitė; Mengyuan Liu; Vinidhra Mani; Donna Neuberg; Thomas B Kepler; Jing H Wang; Frederick W Alt
Journal:  Cell       Date:  2015-11-12       Impact factor: 41.582

7.  Role of Dot1L and H3K79 methylation in regulating somatic hypermutation of immunoglobulin genes.

Authors:  Zhi Duan; Linda B Baughn; Xiaohua Wang; Yongwei Zhang; Varun Gupta; Thomas MacCarthy; Matthew D Scharff; Guojun Yu
Journal:  Proc Natl Acad Sci U S A       Date:  2021-07-20       Impact factor: 11.205

8.  Characterization of DNA G-Quadruplex Structures in Human Immunoglobulin Heavy Variable (IGHV) Genes.

Authors:  Catherine Tang; Thomas MacCarthy
Journal:  Front Immunol       Date:  2021-05-10       Impact factor: 7.561

Review 9.  AID in Chronic Lymphocytic Leukemia: Induction and Action During Disease Progression.

Authors:  Pablo Oppezzo; Marcelo Navarrete; Nicholas Chiorazzi
Journal:  Front Oncol       Date:  2021-05-10       Impact factor: 6.244

10.  Mechanistic basis for chromosomal translocations at the E2A gene and its broader relevance to human B cell malignancies.

Authors:  Di Liu; Yong-Hwee Eddie Loh; Chih-Lin Hsieh; Michael R Lieber
Journal:  Cell Rep       Date:  2021-07-13       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.